Immuno-Oncology Trials for Kidney Cancer, Melanoma and Other Solid Tumors

Immuno-Oncology refers to drugs that change the way cells work. In recent years they have shown increasing promise in treating kidney cancer, melanoma and other solid tumors.

There are two main types of immuno-oncology:

  • Targeted therapies target specific gene mutations to destroy cancer cells
  • Immunotherapy drugs spur the body's immune system to attack the cancer

We are exploring new treatments and novel agents added to existing treatments. We are also studying how to improve the selection criteria for systemic therapy (affecting the entire body) to enhance patient outcomes.

Your physician will help you evaluate whether participation in an immuno-oncology clinical trial is appropriate for you.


See Our Clinical Trials